MFBTD
VRTX icon

MB Financial Bank - Trust Department’s Vertex Pharmaceuticals VRTX Stock Holding History

MB Financial Bank - Trust Department’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-29
Closed -$4K – 453
2015
Q4 		$4K Hold
29
– – ﹤0.01% 403
2015
Q3 		$3K Hold
29
– – ﹤0.01% 520
2015
Q2 		$4K Buy
+29
New +$3.65K ﹤0.01% 475

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

MB Financial Bank - Trust Department's VRTX Position: Q1 2016 in Review

MB Financial Bank - Trust Department sold out of Vertex Pharmaceuticals (VRTX) in Q1 2016, closing a stake of 29 shares — an estimated $4K sold.

MB Financial Bank - Trust Department first reported a position in VRTX in Q2 2015 and held it in 3 quarters. The position peaked at $4K in Q4 2015. 503 funds tracked by Wall St. Rank hold VRTX as of Q1 2016.

  • MB Financial Bank - Trust Department reported no remaining Vertex Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • MB Financial Bank - Trust Department sold 29 Vertex Pharmaceuticals shares in Q1 2016, an estimated $4K.
  • MB Financial Bank - Trust Department first reported a position in Vertex Pharmaceuticals in Q2 2015 and held it in 3 quarters.
  • MB Financial Bank - Trust Department's Vertex Pharmaceuticals position peaked at $4K in Q4 2015.
  • 503 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2016.

Based on MB Financial Bank - Trust Department's 13F filing for Q1 2016, filed 15 Apr 2016.